Point72 Hong Kong LTD Merck & Co., Inc. Call Options Transaction History

Point72 Hong Kong LTD

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $2.68 Million - $3.01 Million	31,700 Added 223.24%	45,900 $3.95 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $2.68 Million - $3.01 Million	31,700 Added 223.24%	45,900 $3.95 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $2.24 Million - $2.54 Million	-26,800 Reduced 65.37%	14,200 $1.3 Million
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $2.57 Million - $2.88 Million	-34,900 Reduced 45.98%	41,000 $3.36 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $3.46 Million - $4.34 Million	47,900 Added 171.07%	75,900 $5.82 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $2.45 Million - $2.7 Million	-34,200 Reduced 54.98%	28,000 $2.1 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $2.13 Million - $2.36 Million	30,300 Added 94.98%	62,200 $4.84 Million
Q1 2021 May 17, 2021	SELL	$68.86 - $81.11 $695,486 - $819,211	-10,100 Reduced 24.05%	31,900 $2.46 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $3.01 Million - $3.35 Million	42,000 New	42,000 $3.44 Million

3,828

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.